etomoxir has been researched along with perhexiline maleate in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (perhexiline maleate) | Trials (perhexiline maleate) | Recent Studies (post-2010) (perhexiline maleate) |
---|---|---|---|---|---|
260 | 8 | 93 | 97 | 2 | 24 |
Protein | Taxonomy | etomoxir (IC50) | perhexiline maleate (IC50) |
---|---|---|---|
G-protein coupled receptor 55 | Homo sapiens (human) | 3.1888 | |
NACHT, LRR and PYD domains-containing protein 1 isoform 1 | Homo sapiens (human) | 12.9 | |
caspase-1 isoform alpha precursor | Homo sapiens (human) | 15.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inglis, S; Stewart, S | 1 |
1 review(s) available for etomoxir and perhexiline maleate
Article | Year |
---|---|
Metabolic therapeutics in angina pectoris: history revisited with perhexiline.
Topics: Acetanilides; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Carnitine O-Palmitoyltransferase; Drug Monitoring; Epoxy Compounds; Fatty Acids; Half-Life; Humans; Metabolic Clearance Rate; Nurse's Role; Nursing Assessment; Patient Education as Topic; Patient Selection; Perhexiline; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2006 |